JP MORGAN/PUT/BOSTON SCIENTIFIC/74/0.1/15.11.24 Share Price

Warrant

DE000JK76EP5

Delayed Börse Stuttgart 11:17:49 25/06/2024 BST
0.45 EUR +2.27% Intraday chart for JP MORGAN/PUT/BOSTON SCIENTIFIC/74/0.1/15.11.24
Current month-21.05%
1 month-22.41%
Date Price Change
25/06/24 0.45 +2.27%
24/06/24 0.44 -6.38%
21/06/24 0.47 -2.08%
20/06/24 0.48 -2.04%
19/06/24 0.49 -3.92%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 11:17 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying BOSTON SCIENTIFIC CORPORATION
Issuer J.P. Morgan
WKN JK76EP
ISINDE000JK76EP5
Date issued 26/04/2024
Strike 74 $
Maturity 15/11/2024 (143 Days)
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.74
Lowest since issue 0.44
Delta-0.34x
Omega 5.517
Premium10.75x
Gearing16.08x
Moneyness 0.9547
Difference Strike -3.51 $
Difference Strike %-4.74%
Spread 0.04
Spread %8.51%
Theoretical value 0.4500
Implied Volatility 37.86 %
Total Loss Probability 56.64 %
Intrinsic value 0.000000
Present value 0.4500
Break even 69.18 €
Theta-0.01x
Vega0.02x
Rho-0.01x

Company Profile

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Sector
-
More about the company

Ratings for Boston Scientific Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Boston Scientific Corporation

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
77.51 USD
Average target price
82.35 USD
Spread / Average Target
+6.25%
Consensus